Press releases
- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
- Sarepta Therapeutics to Present at Upcoming Investor Conferences
- Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program
- Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results
More ▼
Key statistics
On Monday, Sarepta Therapeutics Inc (AB3A:BRN) closed at 118.25, -0.01% below its 52-week high of 118.27, set on Feb 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 118.25 |
---|---|
High | 118.25 |
Low | 118.25 |
Bid | 118.79 |
Offer | 119.52 |
Previous close | 118.25 |
Average volume | -- |
---|---|
Shares outstanding | 94.52m |
Free float | 89.83m |
P/E (TTM) | 1,649.05 |
Market cap | 12.42bn USD |
EPS (TTM) | 0.0797 USD |
Data delayed at least 15 minutes, as of Apr 29 2024.
More ▼